Global Vero Cell Rabies Vaccines for Human Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Vero Cell Rabies Vaccines for Human Industry Forecast” looks at past sales and reviews total world Vero Cell Rabies Vaccines for Human sales in 2022, providing a comprehensive analysis by region and market sector of projected Vero Cell Rabies Vaccines for Human sales for 2023 through 2029. With Vero Cell Rabies Vaccines for Human sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vero Cell Rabies Vaccines for Human industry.
This Insight Report provides a comprehensive analysis of the global Vero Cell Rabies Vaccines for Human landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vero Cell Rabies Vaccines for Human portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vero Cell Rabies Vaccines for Human market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vero Cell Rabies Vaccines for Human and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vero Cell Rabies Vaccines for Human.
The global Vero Cell Rabies Vaccines for Human market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vero Cell Rabies Vaccines for Human is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vero Cell Rabies Vaccines for Human is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vero Cell Rabies Vaccines for Human is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vero Cell Rabies Vaccines for Human players cover Bharat Biotech, Sanofi-Pasteur, Chengda Bio, Prcmise, Zhuoyi Biological, Ningbo Rongan Biological and Indian Immunologicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vero Cell Rabies Vaccines for Human market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Vero Cell Rabies Vaccines for Human market?
What factors are driving Vero Cell Rabies Vaccines for Human market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vero Cell Rabies Vaccines for Human market opportunities vary by end market size?
How does Vero Cell Rabies Vaccines for Human break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Vero Cell Rabies Vaccines for Human Industry Forecast” looks at past sales and reviews total world Vero Cell Rabies Vaccines for Human sales in 2022, providing a comprehensive analysis by region and market sector of projected Vero Cell Rabies Vaccines for Human sales for 2023 through 2029. With Vero Cell Rabies Vaccines for Human sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vero Cell Rabies Vaccines for Human industry.
This Insight Report provides a comprehensive analysis of the global Vero Cell Rabies Vaccines for Human landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vero Cell Rabies Vaccines for Human portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vero Cell Rabies Vaccines for Human market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vero Cell Rabies Vaccines for Human and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vero Cell Rabies Vaccines for Human.
The global Vero Cell Rabies Vaccines for Human market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vero Cell Rabies Vaccines for Human is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vero Cell Rabies Vaccines for Human is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vero Cell Rabies Vaccines for Human is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vero Cell Rabies Vaccines for Human players cover Bharat Biotech, Sanofi-Pasteur, Chengda Bio, Prcmise, Zhuoyi Biological, Ningbo Rongan Biological and Indian Immunologicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vero Cell Rabies Vaccines for Human market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Freeze-dried Powder
- Liquid
- Pre-exposure Prophylaxis
- Post-exposure Prophylaxis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bharat Biotech
- Sanofi-Pasteur
- Chengda Bio
- Prcmise
- Zhuoyi Biological
- Ningbo Rongan Biological
- Indian Immunologicals
What is the 10-year outlook for the global Vero Cell Rabies Vaccines for Human market?
What factors are driving Vero Cell Rabies Vaccines for Human market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vero Cell Rabies Vaccines for Human market opportunities vary by end market size?
How does Vero Cell Rabies Vaccines for Human break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vero Cell Rabies Vaccines for Human Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vero Cell Rabies Vaccines for Human by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vero Cell Rabies Vaccines for Human by Country/Region, 2018, 2022 & 2029
2.2 Vero Cell Rabies Vaccines for Human Segment by Type
2.2.1 Freeze-dried Powder
2.2.2 Liquid
2.3 Vero Cell Rabies Vaccines for Human Sales by Type
2.3.1 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
2.3.2 Global Vero Cell Rabies Vaccines for Human Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vero Cell Rabies Vaccines for Human Sale Price by Type (2018-2023)
2.4 Vero Cell Rabies Vaccines for Human Segment by Application
2.4.1 Pre-exposure Prophylaxis
2.4.2 Post-exposure Prophylaxis
2.5 Vero Cell Rabies Vaccines for Human Sales by Application
2.5.1 Global Vero Cell Rabies Vaccines for Human Sale Market Share by Application (2018-2023)
2.5.2 Global Vero Cell Rabies Vaccines for Human Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vero Cell Rabies Vaccines for Human Sale Price by Application (2018-2023)
3 GLOBAL VERO CELL RABIES VACCINES FOR HUMAN BY COMPANY
3.1 Global Vero Cell Rabies Vaccines for Human Breakdown Data by Company
3.1.1 Global Vero Cell Rabies Vaccines for Human Annual Sales by Company (2018-2023)
3.1.2 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Company (2018-2023)
3.2 Global Vero Cell Rabies Vaccines for Human Annual Revenue by Company (2018-2023)
3.2.1 Global Vero Cell Rabies Vaccines for Human Revenue by Company (2018-2023)
3.2.2 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Company (2018-2023)
3.3 Global Vero Cell Rabies Vaccines for Human Sale Price by Company
3.4 Key Manufacturers Vero Cell Rabies Vaccines for Human Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vero Cell Rabies Vaccines for Human Product Location Distribution
3.4.2 Players Vero Cell Rabies Vaccines for Human Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VERO CELL RABIES VACCINES FOR HUMAN BY GEOGRAPHIC REGION
4.1 World Historic Vero Cell Rabies Vaccines for Human Market Size by Geographic Region (2018-2023)
4.1.1 Global Vero Cell Rabies Vaccines for Human Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vero Cell Rabies Vaccines for Human Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vero Cell Rabies Vaccines for Human Market Size by Country/Region (2018-2023)
4.2.1 Global Vero Cell Rabies Vaccines for Human Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vero Cell Rabies Vaccines for Human Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vero Cell Rabies Vaccines for Human Sales Growth
4.4 APAC Vero Cell Rabies Vaccines for Human Sales Growth
4.5 Europe Vero Cell Rabies Vaccines for Human Sales Growth
4.6 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Growth
5 AMERICAS
5.1 Americas Vero Cell Rabies Vaccines for Human Sales by Country
5.1.1 Americas Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023)
5.1.2 Americas Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023)
5.2 Americas Vero Cell Rabies Vaccines for Human Sales by Type
5.3 Americas Vero Cell Rabies Vaccines for Human Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vero Cell Rabies Vaccines for Human Sales by Region
6.1.1 APAC Vero Cell Rabies Vaccines for Human Sales by Region (2018-2023)
6.1.2 APAC Vero Cell Rabies Vaccines for Human Revenue by Region (2018-2023)
6.2 APAC Vero Cell Rabies Vaccines for Human Sales by Type
6.3 APAC Vero Cell Rabies Vaccines for Human Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vero Cell Rabies Vaccines for Human by Country
7.1.1 Europe Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023)
7.1.2 Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023)
7.2 Europe Vero Cell Rabies Vaccines for Human Sales by Type
7.3 Europe Vero Cell Rabies Vaccines for Human Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vero Cell Rabies Vaccines for Human by Country
8.1.1 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023)
8.2 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Type
8.3 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vero Cell Rabies Vaccines for Human
10.3 Manufacturing Process Analysis of Vero Cell Rabies Vaccines for Human
10.4 Industry Chain Structure of Vero Cell Rabies Vaccines for Human
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vero Cell Rabies Vaccines for Human Distributors
11.3 Vero Cell Rabies Vaccines for Human Customer
12 WORLD FORECAST REVIEW FOR VERO CELL RABIES VACCINES FOR HUMAN BY GEOGRAPHIC REGION
12.1 Global Vero Cell Rabies Vaccines for Human Market Size Forecast by Region
12.1.1 Global Vero Cell Rabies Vaccines for Human Forecast by Region (2024-2029)
12.1.2 Global Vero Cell Rabies Vaccines for Human Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vero Cell Rabies Vaccines for Human Forecast by Type
12.7 Global Vero Cell Rabies Vaccines for Human Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bharat Biotech
13.1.1 Bharat Biotech Company Information
13.1.2 Bharat Biotech Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.1.3 Bharat Biotech Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bharat Biotech Main Business Overview
13.1.5 Bharat Biotech Latest Developments
13.2 Sanofi-Pasteur
13.2.1 Sanofi-Pasteur Company Information
13.2.2 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.2.3 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi-Pasteur Main Business Overview
13.2.5 Sanofi-Pasteur Latest Developments
13.3 Chengda Bio
13.3.1 Chengda Bio Company Information
13.3.2 Chengda Bio Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.3.3 Chengda Bio Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Chengda Bio Main Business Overview
13.3.5 Chengda Bio Latest Developments
13.4 Prcmise
13.4.1 Prcmise Company Information
13.4.2 Prcmise Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.4.3 Prcmise Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Prcmise Main Business Overview
13.4.5 Prcmise Latest Developments
13.5 Zhuoyi Biological
13.5.1 Zhuoyi Biological Company Information
13.5.2 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.5.3 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zhuoyi Biological Main Business Overview
13.5.5 Zhuoyi Biological Latest Developments
13.6 Ningbo Rongan Biological
13.6.1 Ningbo Rongan Biological Company Information
13.6.2 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.6.3 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ningbo Rongan Biological Main Business Overview
13.6.5 Ningbo Rongan Biological Latest Developments
13.7 Indian Immunologicals
13.7.1 Indian Immunologicals Company Information
13.7.2 Indian Immunologicals Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.7.3 Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Indian Immunologicals Main Business Overview
13.7.5 Indian Immunologicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vero Cell Rabies Vaccines for Human Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vero Cell Rabies Vaccines for Human by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vero Cell Rabies Vaccines for Human by Country/Region, 2018, 2022 & 2029
2.2 Vero Cell Rabies Vaccines for Human Segment by Type
2.2.1 Freeze-dried Powder
2.2.2 Liquid
2.3 Vero Cell Rabies Vaccines for Human Sales by Type
2.3.1 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
2.3.2 Global Vero Cell Rabies Vaccines for Human Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vero Cell Rabies Vaccines for Human Sale Price by Type (2018-2023)
2.4 Vero Cell Rabies Vaccines for Human Segment by Application
2.4.1 Pre-exposure Prophylaxis
2.4.2 Post-exposure Prophylaxis
2.5 Vero Cell Rabies Vaccines for Human Sales by Application
2.5.1 Global Vero Cell Rabies Vaccines for Human Sale Market Share by Application (2018-2023)
2.5.2 Global Vero Cell Rabies Vaccines for Human Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vero Cell Rabies Vaccines for Human Sale Price by Application (2018-2023)
3 GLOBAL VERO CELL RABIES VACCINES FOR HUMAN BY COMPANY
3.1 Global Vero Cell Rabies Vaccines for Human Breakdown Data by Company
3.1.1 Global Vero Cell Rabies Vaccines for Human Annual Sales by Company (2018-2023)
3.1.2 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Company (2018-2023)
3.2 Global Vero Cell Rabies Vaccines for Human Annual Revenue by Company (2018-2023)
3.2.1 Global Vero Cell Rabies Vaccines for Human Revenue by Company (2018-2023)
3.2.2 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Company (2018-2023)
3.3 Global Vero Cell Rabies Vaccines for Human Sale Price by Company
3.4 Key Manufacturers Vero Cell Rabies Vaccines for Human Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vero Cell Rabies Vaccines for Human Product Location Distribution
3.4.2 Players Vero Cell Rabies Vaccines for Human Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VERO CELL RABIES VACCINES FOR HUMAN BY GEOGRAPHIC REGION
4.1 World Historic Vero Cell Rabies Vaccines for Human Market Size by Geographic Region (2018-2023)
4.1.1 Global Vero Cell Rabies Vaccines for Human Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vero Cell Rabies Vaccines for Human Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vero Cell Rabies Vaccines for Human Market Size by Country/Region (2018-2023)
4.2.1 Global Vero Cell Rabies Vaccines for Human Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vero Cell Rabies Vaccines for Human Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vero Cell Rabies Vaccines for Human Sales Growth
4.4 APAC Vero Cell Rabies Vaccines for Human Sales Growth
4.5 Europe Vero Cell Rabies Vaccines for Human Sales Growth
4.6 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Growth
5 AMERICAS
5.1 Americas Vero Cell Rabies Vaccines for Human Sales by Country
5.1.1 Americas Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023)
5.1.2 Americas Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023)
5.2 Americas Vero Cell Rabies Vaccines for Human Sales by Type
5.3 Americas Vero Cell Rabies Vaccines for Human Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vero Cell Rabies Vaccines for Human Sales by Region
6.1.1 APAC Vero Cell Rabies Vaccines for Human Sales by Region (2018-2023)
6.1.2 APAC Vero Cell Rabies Vaccines for Human Revenue by Region (2018-2023)
6.2 APAC Vero Cell Rabies Vaccines for Human Sales by Type
6.3 APAC Vero Cell Rabies Vaccines for Human Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vero Cell Rabies Vaccines for Human by Country
7.1.1 Europe Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023)
7.1.2 Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023)
7.2 Europe Vero Cell Rabies Vaccines for Human Sales by Type
7.3 Europe Vero Cell Rabies Vaccines for Human Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vero Cell Rabies Vaccines for Human by Country
8.1.1 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023)
8.2 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Type
8.3 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vero Cell Rabies Vaccines for Human
10.3 Manufacturing Process Analysis of Vero Cell Rabies Vaccines for Human
10.4 Industry Chain Structure of Vero Cell Rabies Vaccines for Human
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vero Cell Rabies Vaccines for Human Distributors
11.3 Vero Cell Rabies Vaccines for Human Customer
12 WORLD FORECAST REVIEW FOR VERO CELL RABIES VACCINES FOR HUMAN BY GEOGRAPHIC REGION
12.1 Global Vero Cell Rabies Vaccines for Human Market Size Forecast by Region
12.1.1 Global Vero Cell Rabies Vaccines for Human Forecast by Region (2024-2029)
12.1.2 Global Vero Cell Rabies Vaccines for Human Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vero Cell Rabies Vaccines for Human Forecast by Type
12.7 Global Vero Cell Rabies Vaccines for Human Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bharat Biotech
13.1.1 Bharat Biotech Company Information
13.1.2 Bharat Biotech Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.1.3 Bharat Biotech Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bharat Biotech Main Business Overview
13.1.5 Bharat Biotech Latest Developments
13.2 Sanofi-Pasteur
13.2.1 Sanofi-Pasteur Company Information
13.2.2 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.2.3 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi-Pasteur Main Business Overview
13.2.5 Sanofi-Pasteur Latest Developments
13.3 Chengda Bio
13.3.1 Chengda Bio Company Information
13.3.2 Chengda Bio Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.3.3 Chengda Bio Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Chengda Bio Main Business Overview
13.3.5 Chengda Bio Latest Developments
13.4 Prcmise
13.4.1 Prcmise Company Information
13.4.2 Prcmise Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.4.3 Prcmise Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Prcmise Main Business Overview
13.4.5 Prcmise Latest Developments
13.5 Zhuoyi Biological
13.5.1 Zhuoyi Biological Company Information
13.5.2 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.5.3 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zhuoyi Biological Main Business Overview
13.5.5 Zhuoyi Biological Latest Developments
13.6 Ningbo Rongan Biological
13.6.1 Ningbo Rongan Biological Company Information
13.6.2 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.6.3 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ningbo Rongan Biological Main Business Overview
13.6.5 Ningbo Rongan Biological Latest Developments
13.7 Indian Immunologicals
13.7.1 Indian Immunologicals Company Information
13.7.2 Indian Immunologicals Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
13.7.3 Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Indian Immunologicals Main Business Overview
13.7.5 Indian Immunologicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vero Cell Rabies Vaccines for Human Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vero Cell Rabies Vaccines for Human Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Freeze-dried Powder
Table 4. Major Players of Liquid
Table 5. Global Vero Cell Rabies Vaccines for Human Sales by Type (2018-2023) & (K Units)
Table 6. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
Table 7. Global Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2023) & ($ million)
Table 8. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2023)
Table 9. Global Vero Cell Rabies Vaccines for Human Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Vero Cell Rabies Vaccines for Human Sales by Application (2018-2023) & (K Units)
Table 11. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2023)
Table 12. Global Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2023)
Table 13. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2018-2023)
Table 14. Global Vero Cell Rabies Vaccines for Human Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Vero Cell Rabies Vaccines for Human Sales by Company (2018-2023) & (K Units)
Table 16. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Company (2018-2023)
Table 17. Global Vero Cell Rabies Vaccines for Human Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Company (2018-2023)
Table 19. Global Vero Cell Rabies Vaccines for Human Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Vero Cell Rabies Vaccines for Human Producing Area Distribution and Sales Area
Table 21. Players Vero Cell Rabies Vaccines for Human Products Offered
Table 22. Vero Cell Rabies Vaccines for Human Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vero Cell Rabies Vaccines for Human Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Vero Cell Rabies Vaccines for Human Sales Market Share Geographic Region (2018-2023)
Table 27. Global Vero Cell Rabies Vaccines for Human Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Vero Cell Rabies Vaccines for Human Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Country/Region (2018-2023)
Table 31. Global Vero Cell Rabies Vaccines for Human Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023) & (K Units)
Table 34. Americas Vero Cell Rabies Vaccines for Human Sales Market Share by Country (2018-2023)
Table 35. Americas Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Vero Cell Rabies Vaccines for Human Revenue Market Share by Country (2018-2023)
Table 37. Americas Vero Cell Rabies Vaccines for Human Sales by Type (2018-2023) & (K Units)
Table 38. Americas Vero Cell Rabies Vaccines for Human Sales by Application (2018-2023) & (K Units)
Table 39. APAC Vero Cell Rabies Vaccines for Human Sales by Region (2018-2023) & (K Units)
Table 40. APAC Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2018-2023)
Table 41. APAC Vero Cell Rabies Vaccines for Human Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2018-2023)
Table 43. APAC Vero Cell Rabies Vaccines for Human Sales by Type (2018-2023) & (K Units)
Table 44. APAC Vero Cell Rabies Vaccines for Human Sales by Application (2018-2023) & (K Units)
Table 45. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023) & (K Units)
Table 46. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Country (2018-2023)
Table 47. Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Vero Cell Rabies Vaccines for Human Revenue Market Share by Country (2018-2023)
Table 49. Europe Vero Cell Rabies Vaccines for Human Sales by Type (2018-2023) & (K Units)
Table 50. Europe Vero Cell Rabies Vaccines for Human Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Vero Cell Rabies Vaccines for Human
Table 58. Key Market Challenges & Risks of Vero Cell Rabies Vaccines for Human
Table 59. Key Industry Trends of Vero Cell Rabies Vaccines for Human
Table 60. Vero Cell Rabies Vaccines for Human Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vero Cell Rabies Vaccines for Human Distributors List
Table 63. Vero Cell Rabies Vaccines for Human Customer List
Table 64. Global Vero Cell Rabies Vaccines for Human Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Vero Cell Rabies Vaccines for Human Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Vero Cell Rabies Vaccines for Human Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Vero Cell Rabies Vaccines for Human Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Vero Cell Rabies Vaccines for Human Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Vero Cell Rabies Vaccines for Human Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Vero Cell Rabies Vaccines for Human Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Vero Cell Rabies Vaccines for Human Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Vero Cell Rabies Vaccines for Human Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Vero Cell Rabies Vaccines for Human Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Vero Cell Rabies Vaccines for Human Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Vero Cell Rabies Vaccines for Human Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bharat Biotech Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 79. Bharat Biotech Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 80. Bharat Biotech Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bharat Biotech Main Business
Table 82. Bharat Biotech Latest Developments
Table 83. Sanofi-Pasteur Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 85. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sanofi-Pasteur Main Business
Table 87. Sanofi-Pasteur Latest Developments
Table 88. Chengda Bio Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 89. Chengda Bio Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 90. Chengda Bio Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Chengda Bio Main Business
Table 92. Chengda Bio Latest Developments
Table 93. Prcmise Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 94. Prcmise Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 95. Prcmise Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Prcmise Main Business
Table 97. Prcmise Latest Developments
Table 98. Zhuoyi Biological Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 99. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 100. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Zhuoyi Biological Main Business
Table 102. Zhuoyi Biological Latest Developments
Table 103. Ningbo Rongan Biological Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 104. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 105. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Ningbo Rongan Biological Main Business
Table 107. Ningbo Rongan Biological Latest Developments
Table 108. Indian Immunologicals Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 109. Indian Immunologicals Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 110. Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Indian Immunologicals Main Business
Table 112. Indian Immunologicals Latest Developments
Table 1. Vero Cell Rabies Vaccines for Human Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vero Cell Rabies Vaccines for Human Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Freeze-dried Powder
Table 4. Major Players of Liquid
Table 5. Global Vero Cell Rabies Vaccines for Human Sales by Type (2018-2023) & (K Units)
Table 6. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
Table 7. Global Vero Cell Rabies Vaccines for Human Revenue by Type (2018-2023) & ($ million)
Table 8. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2023)
Table 9. Global Vero Cell Rabies Vaccines for Human Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Vero Cell Rabies Vaccines for Human Sales by Application (2018-2023) & (K Units)
Table 11. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2023)
Table 12. Global Vero Cell Rabies Vaccines for Human Revenue by Application (2018-2023)
Table 13. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2018-2023)
Table 14. Global Vero Cell Rabies Vaccines for Human Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Vero Cell Rabies Vaccines for Human Sales by Company (2018-2023) & (K Units)
Table 16. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Company (2018-2023)
Table 17. Global Vero Cell Rabies Vaccines for Human Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Company (2018-2023)
Table 19. Global Vero Cell Rabies Vaccines for Human Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Vero Cell Rabies Vaccines for Human Producing Area Distribution and Sales Area
Table 21. Players Vero Cell Rabies Vaccines for Human Products Offered
Table 22. Vero Cell Rabies Vaccines for Human Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vero Cell Rabies Vaccines for Human Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Vero Cell Rabies Vaccines for Human Sales Market Share Geographic Region (2018-2023)
Table 27. Global Vero Cell Rabies Vaccines for Human Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Vero Cell Rabies Vaccines for Human Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Country/Region (2018-2023)
Table 31. Global Vero Cell Rabies Vaccines for Human Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023) & (K Units)
Table 34. Americas Vero Cell Rabies Vaccines for Human Sales Market Share by Country (2018-2023)
Table 35. Americas Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Vero Cell Rabies Vaccines for Human Revenue Market Share by Country (2018-2023)
Table 37. Americas Vero Cell Rabies Vaccines for Human Sales by Type (2018-2023) & (K Units)
Table 38. Americas Vero Cell Rabies Vaccines for Human Sales by Application (2018-2023) & (K Units)
Table 39. APAC Vero Cell Rabies Vaccines for Human Sales by Region (2018-2023) & (K Units)
Table 40. APAC Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2018-2023)
Table 41. APAC Vero Cell Rabies Vaccines for Human Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2018-2023)
Table 43. APAC Vero Cell Rabies Vaccines for Human Sales by Type (2018-2023) & (K Units)
Table 44. APAC Vero Cell Rabies Vaccines for Human Sales by Application (2018-2023) & (K Units)
Table 45. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023) & (K Units)
Table 46. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Country (2018-2023)
Table 47. Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Vero Cell Rabies Vaccines for Human Revenue Market Share by Country (2018-2023)
Table 49. Europe Vero Cell Rabies Vaccines for Human Sales by Type (2018-2023) & (K Units)
Table 50. Europe Vero Cell Rabies Vaccines for Human Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Vero Cell Rabies Vaccines for Human
Table 58. Key Market Challenges & Risks of Vero Cell Rabies Vaccines for Human
Table 59. Key Industry Trends of Vero Cell Rabies Vaccines for Human
Table 60. Vero Cell Rabies Vaccines for Human Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vero Cell Rabies Vaccines for Human Distributors List
Table 63. Vero Cell Rabies Vaccines for Human Customer List
Table 64. Global Vero Cell Rabies Vaccines for Human Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Vero Cell Rabies Vaccines for Human Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Vero Cell Rabies Vaccines for Human Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Vero Cell Rabies Vaccines for Human Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Vero Cell Rabies Vaccines for Human Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Vero Cell Rabies Vaccines for Human Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Vero Cell Rabies Vaccines for Human Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Vero Cell Rabies Vaccines for Human Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Vero Cell Rabies Vaccines for Human Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Vero Cell Rabies Vaccines for Human Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Vero Cell Rabies Vaccines for Human Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Vero Cell Rabies Vaccines for Human Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bharat Biotech Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 79. Bharat Biotech Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 80. Bharat Biotech Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bharat Biotech Main Business
Table 82. Bharat Biotech Latest Developments
Table 83. Sanofi-Pasteur Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 85. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sanofi-Pasteur Main Business
Table 87. Sanofi-Pasteur Latest Developments
Table 88. Chengda Bio Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 89. Chengda Bio Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 90. Chengda Bio Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Chengda Bio Main Business
Table 92. Chengda Bio Latest Developments
Table 93. Prcmise Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 94. Prcmise Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 95. Prcmise Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Prcmise Main Business
Table 97. Prcmise Latest Developments
Table 98. Zhuoyi Biological Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 99. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 100. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Zhuoyi Biological Main Business
Table 102. Zhuoyi Biological Latest Developments
Table 103. Ningbo Rongan Biological Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 104. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 105. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Ningbo Rongan Biological Main Business
Table 107. Ningbo Rongan Biological Latest Developments
Table 108. Indian Immunologicals Basic Information, Vero Cell Rabies Vaccines for Human Manufacturing Base, Sales Area and Its Competitors
Table 109. Indian Immunologicals Vero Cell Rabies Vaccines for Human Product Portfolios and Specifications
Table 110. Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Indian Immunologicals Main Business
Table 112. Indian Immunologicals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vero Cell Rabies Vaccines for Human
Figure 2. Vero Cell Rabies Vaccines for Human Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vero Cell Rabies Vaccines for Human Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Vero Cell Rabies Vaccines for Human Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vero Cell Rabies Vaccines for Human Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Freeze-dried Powder
Figure 10. Product Picture of Liquid
Figure 11. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type in 2022
Figure 12. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2023)
Figure 13. Vero Cell Rabies Vaccines for Human Consumed in Pre-exposure Prophylaxis
Figure 14. Global Vero Cell Rabies Vaccines for Human Market: Pre-exposure Prophylaxis (2018-2023) & (K Units)
Figure 15. Vero Cell Rabies Vaccines for Human Consumed in Post-exposure Prophylaxis
Figure 16. Global Vero Cell Rabies Vaccines for Human Market: Post-exposure Prophylaxis (2018-2023) & (K Units)
Figure 17. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2022)
Figure 18. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application in 2022
Figure 19. Vero Cell Rabies Vaccines for Human Sales Market by Company in 2022 (K Units)
Figure 20. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Company in 2022
Figure 21. Vero Cell Rabies Vaccines for Human Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Company in 2022
Figure 23. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Vero Cell Rabies Vaccines for Human Sales 2018-2023 (K Units)
Figure 26. Americas Vero Cell Rabies Vaccines for Human Revenue 2018-2023 ($ Millions)
Figure 27. APAC Vero Cell Rabies Vaccines for Human Sales 2018-2023 (K Units)
Figure 28. APAC Vero Cell Rabies Vaccines for Human Revenue 2018-2023 ($ Millions)
Figure 29. Europe Vero Cell Rabies Vaccines for Human Sales 2018-2023 (K Units)
Figure 30. Europe Vero Cell Rabies Vaccines for Human Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue 2018-2023 ($ Millions)
Figure 33. Americas Vero Cell Rabies Vaccines for Human Sales Market Share by Country in 2022
Figure 34. Americas Vero Cell Rabies Vaccines for Human Revenue Market Share by Country in 2022
Figure 35. Americas Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
Figure 36. Americas Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2023)
Figure 37. United States Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Vero Cell Rabies Vaccines for Human Sales Market Share by Region in 2022
Figure 42. APAC Vero Cell Rabies Vaccines for Human Revenue Market Share by Regions in 2022
Figure 43. APAC Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
Figure 44. APAC Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2023)
Figure 45. China Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Country in 2022
Figure 53. Europe Vero Cell Rabies Vaccines for Human Revenue Market Share by Country in 2022
Figure 54. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
Figure 55. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2023)
Figure 56. Germany Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2023)
Figure 65. Egypt Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Vero Cell Rabies Vaccines for Human in 2022
Figure 71. Manufacturing Process Analysis of Vero Cell Rabies Vaccines for Human
Figure 72. Industry Chain Structure of Vero Cell Rabies Vaccines for Human
Figure 73. Channels of Distribution
Figure 74. Global Vero Cell Rabies Vaccines for Human Sales Market Forecast by Region (2024-2029)
Figure 75. Global Vero Cell Rabies Vaccines for Human Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Vero Cell Rabies Vaccines for Human Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Vero Cell Rabies Vaccines for Human Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Vero Cell Rabies Vaccines for Human Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Vero Cell Rabies Vaccines for Human Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Vero Cell Rabies Vaccines for Human
Figure 2. Vero Cell Rabies Vaccines for Human Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vero Cell Rabies Vaccines for Human Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Vero Cell Rabies Vaccines for Human Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vero Cell Rabies Vaccines for Human Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Freeze-dried Powder
Figure 10. Product Picture of Liquid
Figure 11. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type in 2022
Figure 12. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2018-2023)
Figure 13. Vero Cell Rabies Vaccines for Human Consumed in Pre-exposure Prophylaxis
Figure 14. Global Vero Cell Rabies Vaccines for Human Market: Pre-exposure Prophylaxis (2018-2023) & (K Units)
Figure 15. Vero Cell Rabies Vaccines for Human Consumed in Post-exposure Prophylaxis
Figure 16. Global Vero Cell Rabies Vaccines for Human Market: Post-exposure Prophylaxis (2018-2023) & (K Units)
Figure 17. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2022)
Figure 18. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application in 2022
Figure 19. Vero Cell Rabies Vaccines for Human Sales Market by Company in 2022 (K Units)
Figure 20. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Company in 2022
Figure 21. Vero Cell Rabies Vaccines for Human Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Company in 2022
Figure 23. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Vero Cell Rabies Vaccines for Human Sales 2018-2023 (K Units)
Figure 26. Americas Vero Cell Rabies Vaccines for Human Revenue 2018-2023 ($ Millions)
Figure 27. APAC Vero Cell Rabies Vaccines for Human Sales 2018-2023 (K Units)
Figure 28. APAC Vero Cell Rabies Vaccines for Human Revenue 2018-2023 ($ Millions)
Figure 29. Europe Vero Cell Rabies Vaccines for Human Sales 2018-2023 (K Units)
Figure 30. Europe Vero Cell Rabies Vaccines for Human Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue 2018-2023 ($ Millions)
Figure 33. Americas Vero Cell Rabies Vaccines for Human Sales Market Share by Country in 2022
Figure 34. Americas Vero Cell Rabies Vaccines for Human Revenue Market Share by Country in 2022
Figure 35. Americas Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
Figure 36. Americas Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2023)
Figure 37. United States Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Vero Cell Rabies Vaccines for Human Sales Market Share by Region in 2022
Figure 42. APAC Vero Cell Rabies Vaccines for Human Revenue Market Share by Regions in 2022
Figure 43. APAC Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
Figure 44. APAC Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2023)
Figure 45. China Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Country in 2022
Figure 53. Europe Vero Cell Rabies Vaccines for Human Revenue Market Share by Country in 2022
Figure 54. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
Figure 55. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2023)
Figure 56. Germany Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2018-2023)
Figure 65. Egypt Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Vero Cell Rabies Vaccines for Human Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Vero Cell Rabies Vaccines for Human in 2022
Figure 71. Manufacturing Process Analysis of Vero Cell Rabies Vaccines for Human
Figure 72. Industry Chain Structure of Vero Cell Rabies Vaccines for Human
Figure 73. Channels of Distribution
Figure 74. Global Vero Cell Rabies Vaccines for Human Sales Market Forecast by Region (2024-2029)
Figure 75. Global Vero Cell Rabies Vaccines for Human Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Vero Cell Rabies Vaccines for Human Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Vero Cell Rabies Vaccines for Human Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Vero Cell Rabies Vaccines for Human Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Vero Cell Rabies Vaccines for Human Revenue Market Share Forecast by Application (2024-2029)
